Which is the correct reporting frequency for dispensing Schedule II and III drugs to CURES?

Dispensing Schedule II and III drugs to the CURES (Controlled Substance Utilization Review and Evaluation System) must be reported monthly. This requirement is in place to ensure that there is timely monitoring of controlled substances to combat the misuse and abuse of these medications. The monthly reporting allows for healthcare professionals, regulatory bodies, and law enforcement to have current information on prescribed and dispensed controlled substances, enhancing patient safety and public health.

This frequency is especially important for Schedule II and III drugs, which have a higher potential for abuse and addiction, necessitating closer oversight. By reporting monthly, it enables quicker interventions when potential abuse patterns are detected, helping in effective management of patients' treatment plans and reducing the risk of drug diversion.